Trial Profile
A phase III, placebo controlled study investigating liposomal recombinant human Cu/Zn-superoxide dismutase (Lipoxysan) in patients with Peyronie′s disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Feb 2016
Price :
$35
*
At a glance
- Drugs Superoxide dismutase (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
- 19 Feb 2016 New trial record